Our team at Metric Bio ensures transparent communication, using their specialised industry knowledge, to help our partners get the most out of their experience with us. Why not see for yourself? Get in touch with one of our world-class talent acquisition specialists today. Visit our jobs page to see where your next career change could take you and read below about some of our current available roles. https://lnkd.in/eFaZ2U3D #MetricBio #CurrentRoles #Worldwide
About us
Utilizing our expertise to provide recruitment solutions to some of the worlds most cutting-edge companies in MedTech and Life Science. Our world-leading team of expert’s passion lies in deliver cutting edge talent solutions to visionary clients, positively impacting human health within a variety of specialisms including: - Biotech - CDMO - CRO - MedTech New York | London | Florida | Nottingham
- Website
-
http://www.metric-search.com
External link for Metric Bio
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- New York
- Type
- Privately Held
- Specialties
- Biotech , Genomics, Lab Automation, Cell & Gene Therapy, Cellular Agriculture, CDMO, Biologics, Drug Products, API, CRO, Pre-Clinical, Clinical, E-Clinical, Clinical Trial Supply, Drug Discovery, Digital Health, HealthTech, Artificial Intelligence, SaaS, Telemedicine, MedTech, Neurotech, FemTech, Cardiovascular, Medical Imagine & AI, Surgical Robotics, Orthopaedic and Spine, Pharma, and Molecular Diagnostics
Locations
-
Primary
New York, US
-
Fort Lauderdale, US
-
London, GB
-
Nottingham, GB
Employees at Metric Bio
Updates
-
At Metric Bio, we have a commitment to the continuous development of long-lasting, meaningful relationships through trust, honest communication and shared goals to ensure a sustainable and successful future for all our candidates and clients. Alex Alves-Khan is a testament to this value at Metric Bio and we’re not the only ones that think so. Why not read below about Kyle J. Lauterbach, MBA, PMP’s experience with Alex Alves-Khan in securing him a position at Scorpius BioManufacturing, Inc., and visit Alex's webpage to read more about his track record. https://lnkd.in/dzBW-RXn #MetricBio #Testimony #ScorpiusBioManufacturing
-
James Barraclough is a highly experienced Senior Group Business Manager at Metric Bio, providing prime talent acquisition solutions for the global medical device market. James Barraclough prides himself on his knowledge of the industry, even hosting his own podcast, "The MedTech Pulse," where he discusses all things related to medical technology. The podcast is available to listen to now on Spotify - https://lnkd.in/gTMrWhaT Why not watch the snippet below of James Barraclough’s interview with Daniel Perez about Hinge Health and their digital clinic for joint and muscle care? And visit James Barraclough’s webpage to learn more about his amazing track record. https://lnkd.in/gvUSiq25 #MetricBio #Testimony #Podcast #Medtech
-
Eli Lilly and Company is acquiring Morphic Therapeutic a biopharmaceutical leader in oral integrin therapies for chronic diseases. Daniel Skovronsky, Lilly’s Chief Scientific Officer, stated, "Oral therapies like MORF-057 could revolutionize early intervention and combination treatments for diseases such as ulcerative colitis. We eagerly welcome the Morphic team to Lilly." Key Details: - Lilly will acquire all Morphic shares for $57 each, totalling approximately $3.2 billion. - The transaction, expected to close in Q3 2024, represents a 79% premium to Morphic's July 5, 2024 closing price. Read below to learn more about this deal. https://lnkd.in/dqjx6JTb #MetricBio #Lilly #MorphicHolding #Biopharma #HealthcareInnovation
-
Charles River Laboratories and AAVantgarde Bio have entered a CDMO agreement to produce GMP plasmid DNA. AAVantgarde Bio, with its innovative AAV vector platforms for large gene delivery, will use Charles River Laboratories' expertise to advance treatments for inherited retinal diseases, beginning with Stargardt's disease. Stargardt's, the most common inherited macular dystrophy, affects 1 in 6,500 people and currently has no therapies. This partnership leverages Charles River Laboratories’ GMP plasmid DNA CDMO center in Keele, UK, to support AAVantgarde Bio's Stargardt's disease program. Read more below about this agreement. https://lnkd.in/eV23ymd9 #CharlesRiver #AAVantgarde #GeneTherapy #CDMO #HealthcareInnovation
Charles River to Perform Plasmid Manufacturing for AAVantgarde
lelezard.com
-
Check out our most recently published job roles to see where your next career change could take you and discover more about our talented team at Metric Bio by visiting our website. https://lnkd.in/enq8Qiwc #MetricBio #Recruitment #Onsite #TalentAcquisition
-
-
Happy 4th of July from Metric Bio! We hope everyone enjoys a fantastic day filled with fun, relaxation, and great company. Whether you're watching fireworks, having a barbecue, or just kicking back, enjoy the holiday! From all of us at Metric Bio, have a safe and happy Independence Day! #FourthOfJuly #Metric #Celebrate #Recruitmen
-
-
John-Joe Walker’s promotion to Chief Commercial Officer is a testament to his work and dedication to Metric Bio as a world-leading MedTech search partner. Read about Anthony Arnold’s experience with John-Joe Walker, and visit John-Joe’s webpage to learn more about his incredible track record. https://lnkd.in/efmVNGaQ #MetricBio #Recruitment #CCO
-
-
Exciting Leadership Update at Lonza! Our partner Lonza recently welcomed their new Chief Executive Officer Dr. Wolfgang Wienand! Jean-Marc Huët, Chairman of the Board of Directors at Lonza, shared, “We are excited to have Dr. Wolfgang Wienand on board. His extensive experience in the CDMO industry, coupled with his strategic and scientific expertise, positions him perfectly to lead Lonza into a future of stable and structured growth.” Dr. Wolfgang Wienand commented, “It is an honor to join Lonza as CEO. I have always admired Lonza’s rapid transformation and growth. I am eager to work with the team to continue meeting and exceeding the needs of our customers and their patients, building on our strong foundation to achieve our full potential.” Wolfgang brings a wealth of experience, having previously served as CEO of Swiss CDMO Siegfried, and holding senior roles at Evonik Industries. Learn more about our partners new CEO on their website and discover more about Lonza’s commitment to healthcare manufacturing. https://lnkd.in/ew9s8ga3 #MetricBio #Lonza #LeadershipUpdate #CEO #HealthcareInnovation
Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand
lonza.com
-
Exciting News from ProBio! GenScript ProBio has launched a new manufacturing facility in Hopewell, New Jersey, expanding their plasmid DNA and viral vector production capabilities! This 128,000-square-foot site will be the central hub for ProBio’s cell and gene therapy production in North America. As Patrick Liu, ProBio’s chairman, said, “The Hopewell facility exemplifies our mission to bring innovative therapies from concept to reality.” Launched in 2020, ProBio secured $224 million in early 2023 boosting manufacturing capacity. The new facility offers comprehensive services, including tech transfer, method and analytical development, process development, and drug product manufacturing for both clinical and commercial-grade therapies. Read more about their expansion below – https://lnkd.in/eZT42H6R #MetricBio #Recruitment #Pharmaceutical #CDMO
GenScript's ProBio arm debuts new gene therapy production plant in NJ
fiercepharma.com